Phase IB study of dovitinib in combination with gemcitabine plus cisplatin or gemcitabine plus carboplatin in patients with advanced solid tumors
ID Number 11-0946
Principal Investigator(s)Matthew Galsky
Department(s) or Division(s)
Hematology and Medical Oncology
Description
null
Contact Information
null
Recruiting Patients: Yes

